CREXAVIBART

UNII:	ME6UG23L4A
Formula:
Preferred Substance Name:	CREXAVIBART
GSRS Full Record:	ME6UG23L4A i

2599039-61-7
6XJM493A42
BMS-986413
C144-LS
C-144-LS
CREXAVIBART [INN]
CREXAVIBART [USAN]
CREXAVIBART [WHO-DD]
IM051 COMPONENT CREXAVIBART
IM-051 COMPONENT CREXAVIBART
IMMUNOGLOBULIN G1 (442-LEUCINE,448-SERINE,DE-461-LYSINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL C144 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL C144 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME (HUMAN) CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBOD

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CREXAVIBART

Synonyms and Mappings

Resources